Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies
 

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Article DOI: 10.3791/55542-v 07:25 min May 4th, 2017
May 4th, 2017

Chapters

Summary

This protocol describes the in vitro comparison of two key functional characteristics of rituximab: target binding and complement-dependent cytotoxicity (CDC) induction. The methods were employed for a side-to-side comparison between reference rituximab and a rituximab biosimilar. These assays can be employed during biosimilar development or as a quality control in their production.

Tags

Keywords: Therapeutic Antibodies Biosimilarity Analysis Target Binding Complement-dependent Cytotoxicity (CDC) Induction In Vitro Methods Rituximab Daudi Cells Reference Product Biosimilar Quality Control
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter